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A B S T R A C T
Background
Endoscopy and surgery are the treatment modalities of choice in patients with obstructive chronic pancreatitis. Physicians face the
decision between endoscopy and surgery for this group of patients, without clear consensus.
Objectives
To assess and compare the effectiveness and complications of surgical and endoscopic interventions in the management of pain for
obstructive chronic pancreatitis.
Search methods
We searched The Cochrane Library, MEDLINE, EMBASE and the Conference Proceedings Citation Index; and performed a cross-
reference search. Two review authors performed the selection of trials independently.
Selection criteria
All randomised controlled trials (RCTs) investigating endoscopic or surgical interventions for obstructive chronic pancreatitis. All trials
were included irrespective of blinding, number of patients randomised and language of the article.
Data collection and analysis
Two authors independently extracted data from the articles. The methodological quality of included trials was evaluated. Authors were
requested additional information in the case of missing data.
Main results
We screened 2082 publications and identified three eligible trials. Two trials compared endoscopic intervention to surgical intervention.
These included a total of 111 patients, 55 in the endoscopic group and 56 in the surgical group. A higher proportion of patients with
pain relief was found in the surgical group compared to the endoscopic group (partial or complete pain relief: RR 1.62, 95% confidence
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interval (CI) 1.11 to 2.37; complete pain relief: RR 2.45, 95% CI 1.18 to 5.09). Surgical intervention resulted in improved quality
of life and improved preservation of exocrine pancreatic function in one trial. The number of patients did not allow for a reliable
evaluation of morbidity and mortality between the two treatment modalities. One trial compared surgical intervention to conservative
treatment. It included 32 patients: 17 in the surgical group and 15 in the conservative group. The trial showed that surgical intervention
resulted in a higher percentage of patients with pain relief and better preservation of pancreatic function. The trial had methodological
limitations and the number of patients was relatively small.
Authors’ conclusions
For patients with obstructive chronic pancreatitis and dilated pancreatic duct, this review showed that surgery is superior to endoscopy
in terms of pain control. Morbidity and mortality seemed not to differ between the two intervention modalities, but the small trials
identified do not provide sufficient power to detect the small differences expected in this outcome.
Regarding the comparison of surgical intervention versus conservative treatment, this review has shown that surgical intervention in
an early stage of chronic pancreatitis seems to be a promising approach in terms of pain control and pancreatic function. Confirmation
of these results is needed in other trials due to the methodological limitations and limited number of patients of the present evidence.
P L A I N L A N G U A G E S U M M A R Y
Endoscopy or surgery for patients with chronic pancreatitis and dilated pancreatic duct
Endoscopy and surgery are the treatments of choice in patients with chronic pancreatitis and a dilated pancreatic duct. In this review
we compared these two intervention modalities. We found that surgery achieved pain relief in a higher proportion of patients than
with endoscopy. Surgery also had other advantages like improved quality of life and reduced risk of developing exocrine pancreatic
insufficiency. The studies seemingly showed no difference in complications after intervention between endoscopy and surgery, but
lacked the power to establish this with sufficient reliability. We also compared surgery to conservative treatment. Results of one trial
suggested that surgery early in the disease achieved better pain relief and preservation of pancreatic function. The trial, however, was
small, which precluded drawing reliable conclusions.
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B A C K G R O U N D
Description of the condition
Chronic pancreatitis (CP) is a progressive inflammatory condition
of the pancreas characterised by severe pain and damage to en-
docrine and exocrine pancreatic tissue. The incidence and preva-
lence of chronic pancreatitis inWestern Europe are estimated to be
around seven and 26 per 100,000, respectively (Dite 2001; Levy
2006; Spanier 2008). The etiology of CP is a complex multifacto-
rial process (Witt 2007). In theWestern world alcohol is the lead-
ing contributing factor. Genetics, auto-immunity, metabolic ab-
normalities (hypertriglyceridaemia, hypercalcaemia) and anatom-
ical malformations (pancreas divisum) play a role as well in the
development of CP (Witt 2007).
Pain is the characteristic clinical symptom of CP. Management of
this disease is, therefore, mostly focused towards pain alleviation
(AGA 1998; van Esch 2006). Longstanding CP is also associated
with development of endocrine and exocrine insufficiency, which
may result in diabetes, malabsorption, weight loss and deterio-
ration of the patient’s general condition (Pezzilli 2005; Wehler
2004). Additionally, CP can be complicated by pancreatic pseu-
docyst formation, abscess formation, stenosis of the common bile
duct and an increased risk of pancreatic cancer (Lankisch 2001).
Description of the intervention
In patients with obstructive CP it is believed that ductal and
parenchymal hypertension, caused by an elevated pressure in the
main pancreatic duct, is the source of pain (Fasanella 2007). Fi-
brosis within the chronically inflamed pancreas is assumed to con-
tribute to elevated pressure by limiting the ability of the gland
to expand during periods of exocrine secretion (Fasanella 2007;
Gourgiotis 2007). Strictures and elevated pressure are contributing
factors to the formationof stones in the pancreatic duct, whichmay
further limit the ability of the gland to excrete its exocrine prod-
ucts normally. Endoscopy and surgery are considered the treat-
ment modalities of choice in the case of painful obstructive pan-
creatitis. The aim of both modalities is to alleviate the pressure
of the pancreatic duct and ensure adequate drainage of pancreatic
excretions.
How the intervention might work
Endoscopic therapy attempts to relieve the pressure in the pancre-
atic duct by ensuring good drainage of pancreatic juices into the
intestines. This is typically done by means of endoscopic retro-
grade cholangiopancreatography (ERCP). Endoscopic treatment
may involve papillotomy of the papilla of Vater, dilation of stric-
tures, removal of stones (with or without lithotrypsy) and place-
ment of stents in the pancreatic duct (Rösch 2002). Endoscopic
intervention is less invasive than surgery and patients can usually
be discharged in about one to two days. Usually, however, more
than one endoscopic intervention is needed to achieve satisfactory
results, and in some patients subsequent surgery is still needed.
Overall, endoscopic treatment achieves complete or partial pain
relief in approximately 74% of patients (van der Gaag 2007).
Surgical interventions for CP can be classified into resection and
drainage procedures (Gourgiotis 2007; van der Gaag 2007). In
a drainage procedure the pancreatic duct is opened over its full
length and subsequently a side-to-side anastomosis with the je-
junum is performed (that is pancreaticojejunostomy). In resection
procedures, the affected head or tail of the pancreas is resected.
After duodenum preserving pancreatic head (Beger) resection or
pancreaticoduodenectomy the open end of the remnant pancre-
atic duct is connected to the small bowel. For distal pancreatic
(pancreatic tail) resections a bowel connection for drainage is not
routinely needed. There are alsomixed drainage and resection pro-
cedures, in which a local pancreatic resection (mostly of the pan-
creatic head) is combined with a partial drainage procedure (for
example Frey or Bern operations) (Strate 2005). Patients typically
remain hospitalized for one to two weeks after surgery (Cahen
2007). Surgical interventions accomplish partial or complete pain
relief in approximately 80% of patients (van der Gaag 2007).
Why it is important to do this review
There is no clear consensus regarding the decision between en-
doscopy and surgery for patients with painful obstructive CP.
Several reviews describe results of endoscopic and surgical proce-
dures separately, but inference from these reports is difficult due to
the lack of head-to-head comparisons (Gourgiotis 2007; Tringali
2008; van der Gaag 2007). One review of randomised clinical tri-
als on endoscopic versus surgical interventions was published re-
cently, but themethodology was not explicit and the review lacked
a clear conclusion (Deviere 2008). We, therefore, aimed to review
and summarise the evidence for both treatment modalities.
O B J E C T I V E S
To assess and compare the effectiveness and complications of sur-
gical and endoscopic interventions in the management of pain for
obstructive chronic pancreatitis.
M E T H O D S
Criteria for considering studies for this review
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Types of studies
All randomised controlled trials (RCTs) investigating endoscopic
or surgical interventions for obstructive chronic pancreatitis (that
is with a dilated panceatic duct). All trials were included irrespec-
tive of blinding, number of patients randomised and language of
the article.
Types of participants
Trials including adults with confirmed chronic pancreatitis (CP),
pancreatic duct dilation and pain were eligible for this review. Pain
was the primary indication for the interventions.
Types of interventions
Studies with any of the following comparisons were included.
• Endoscopic versus surgical intervention.
• Endoscopic intervention versus conservative treatment.
• Surgical intervention versus conservative treatment.
We used the following definitions for the different treatment
modalities.
• Endoscopic intervention: an endoscopic retrograde
cholangiopancreatography (ERCP) performed with therapeutic
intent and in which one of papillotomy, dilation of the pancreatic
duct or placement of a pancreatic ductal stent was performed.
• Surgical intervention: any surgical procedure used for the
treatment of obstructive CP, including pancreaticojejunostomy
(PJ), resection-drainage procedures (e.g. Frey, Beger) or a
(pylorus preserving) pancreaticoduodenectomy.
• Conservative treatment: non-invasive therapy, mainly
medical treatment for pain and nutritional supportive treatment.
Types of outcome measures
Primary outcomes
• Pain relief: proportion of patients achieving pain relief
compared to the situation prior to intervention. Since pain is a
subjective outcome and many different scores are used, we did
not use a strict definition of pain relief. We classified the
observed pain relief as either complete or partial. Partial pain
relief was defined as a decrease in pain of at least 50% compared
to baseline, without achieving complete pain relief. We
conducted analysis for complete and partial pain relief separately,
and for total proportion of patients experiencing pain relief
(both partial and complete).
• Major post-interventional complications, including intra-
abdominal abscess, ileus necessitating surgery, pancreatitis flare-
up, bleeding, anastomotic leakage, sepsis, abdominal fascial
dehiscence (Platzbauch) and myocardial infarction.
• Mortality.
Secondary outcomes
• Quality of life.
• Minor post-interventional complications: these included
wound infections, pneumonia, cholecystitis, prolonged ileus (not
necessitating intervention), fistulas, urinary tract infections,
urinary retention and deep venous thrombosis.
• New onset endocrine and exocrine pancreatic insufficiency.
• Number of endoscopic and surgical procedures related to
the treatment of CP.
• Change in nutritional status (body weight or body mass
index (BMI)) after intervention.
• Duration of hospital stay.
Search methods for identification of studies
Electronic searches
We searched the following databases.
• The Cochrane Library, 2011, Issue 4 (search strategy in
Appendix 1):
◦ Cochrane Database of Systematic Reviews;
◦ Database of Abstracts of Reviews of Effects (DARE);
◦ Cochrane Central Register of Controlled Trials
(CENTRAL).
• MEDLINE via Ovid (from 1950 to November 2011)
(Appendix 2).
• EMBASE via Ovid (from 1980 to November 2011)
(Appendix 3).
• Conference Proceedings Citation Index - Science (CPCI-S)
(from 1990 to February 2010) (Appendix 4).
We developed the search strategies in cooperation with the
Cochrane Upper Gastrointestinal and Pancreatic Diseases Group
(see Acknowledgements).
Searching other resources
We performed a cross-reference search of all included randomised
trials and relevant reviews identified during the search process.
We also requested additional information by letter or e-mail from
all authors of included trials on any published, unpublished or
ongoing trials.
Data collection and analysis
We conducted this review according to the recommendations of
the Cochrane Handbook for Systematic Review of Interventions (
Higgins 2008).
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Selection of studies
Two review authors (UAA and JMP) performed the selection of
trials independently. First, they screened titles and abstracts and se-
lected all potentially relevant publications, including those where
the relevance was uncertain. Subsequently, they reviewed the full-
text of all selected publications and selected trials meeting the se-
lection criteria. In the case of disagreements consensus was reached
by discussion.
Data extraction and management
Two review authors (UAA and JMP) independently extracted all
relevant data. For each study the review authors extracted patient
characteristics, study characteristics, data needed for the method-
ological quality assessment of the study and the primary and sec-
ondary outcomes, according to availability. Data regarding patient
characteristics included number of patients in each group, age,
gender, BMI and type of pain (A or B) according to the Ammann
classification (Ammann 1999). Data regarding study characteris-
tics included study design, sample size information, inclusion and
exclusion criteria of the study, follow-up period, loss to follow-
up, surgical and endoscopic experience and information regarding
surgical and endoscopic techniques. These data are presented in
the Characteristics of included studies table.
Assessment of risk of bias in included studies
Based on the recommendations of the Cochrane Handbook for Sys-
tematic Reviews of Interventions and available literature, we assessed
the methodological quality of RCTs by using the tool for assessing
risk of bias (Higgins 2008; Kjaergard 2001; Moher 1998; Schulz
1995). We used the following definitions of the items in this tool.
Sequence allocation
• Adequate, if the allocation sequence was generated by a
computer or random number table. Drawing of lots, tossing of a
coin, shuffling of cards, or throwing dice was considered
adequate if a person who was not otherwise involved in the
recruitment of participants performed the procedure.
• Unclear, if the trial was described as randomised but the
method used for generation of the allocation sequence was not
described.
• Inadequate, if a system involving dates, names or
alternating allocation was used for the allocation of patients.
Allocation concealment
• Adequate, if the allocation of patients involved a central
independent unit, on-site locked computer, or sealed envelopes.
• Unclear, if the trial was described as randomised but the
method used to conceal the allocation was not described.
• Inadequate, if the allocation sequence was known to the
investigators who assigned the participants.
Blinding
• Adequate, if the trial was described as blind to participants
or assessors and the method of blinding was described. We are
well aware that it is very difficult to properly blind trials
comparing endoscopic or surgical treatments.
• Unclear, if the trial was described as (double) blind, but the
method of blinding was not described.
• Inadequate, if the trial was not blinded.
Incomplete data outcome
• Adequate, if the percentage of dropouts did not exceed
20%, and numbers and reasons for dropouts and withdrawals in
all intervention groups were described.
• Unclear, if the report gave the impression that there had
been no dropouts or withdrawals but this was not specifically
stated.
• Inadequate, if the percentage of dropouts exceeded 20%, or
the numbers and reasons for dropouts and withdrawals were not
described.
Selective outcome reporting
• Adequate, when it was clear that the published reports
included all expected outcomes, including those that were pre-
specified.
• Unclear, if insufficient information was provided to permit
clear judgement of this aspect.
• Inadequate, if all relevant outcomes and all the study’s pre-
specified outcomes were not reported, or if they were
incompletely reported.
Other sources of bias
• Adequate, if the study appeared to be free of other sources
of bias.
• Unclear, if a risk of potentially important bias existed but
sufficient information to assess this bias was lacking.
• Inadequate, if one or more sources of potentially important
biases could be identified in the study (e.g. extreme baseline
imbalances or other imbalances in study design).
Measures of treatment effect
We conducted statistical analysis of binary data using risk ratio
(RR) as the summary statistic. For continuous outcomes we used
mean differences (MD) as the summary statistic.
Assessment of heterogeneity
We calculated the heterogeneity using the Chi2 test and quantified
the inconsistency in study effects by the I2 statistic (Higgins 2002).
We considered a Chi2 test with a P value of < 0.10 to indicate the
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presence of heterogeneity, and an I2 statistic > 50% to suggest a
marked inconsistency in effect between studies.
Assessment of reporting biases
Due to the low number of identified studies, funnel plots were not
useful in assessing the presence of publication bias. We, therefore,
refrained from using them.
Data synthesis
Depending on the availability of appropriate evidence, we con-
ducted the following comparisons in this review.
• Endoscopic intervention versus surgical intervention.
• Endoscopic intervention versus conservative treatment.
• Surgical intervention versus conservative treatment.
If appropriate data were available, meta-analysis was conducted.
Otherwise, we conducted a narrative review of the identified evi-
dence. For the meta-analysis, we used the fixed-effect model if no
heterogeneity was present (Chi2 test P > 0.1 and I2 < 50%). In all
other cases we used the random-effects model.
Due to insufficient numbers of trials, we were not able to perform
a subgroup analysis according to the methodological quality of
the included trials. The methodological quality of trials has been
presented using the criteria of the risk of bias assessment tool
described earlier, and has been taking into consideration when
discussing the results of the review.
We conducted statistical analysis using the statistical package Re-
view Manager (RevMan) provided by The Cochrane Collabora-
tion.
R E S U L T S
Description of studies
See:Characteristics of included studies; Characteristics of excluded
studies; Characteristics of ongoing studies.
Results of the search
Weperformed the search on3November 2011 andobtained a total
of 2082 publications.We screened titles and abstract of all publica-
tions and excluded 2060 publications. Twenty-two potentially rel-
evant publications remained for full-text reviewing. One publica-
tion was a study protocol of an ongoing trial (see Characteristics of
ongoing studies). Two publications described a randomised trial of
endoscopy versus extracorporeal shock-wave lithotripsy (ESWL).
Since ESWL can not be considered as conservative treatment, this
trial did not fulfil our inclusion criteria and was excluded (see
Characteristics of excluded studies). Eleven publications were ex-
cluded for other reason (see Characteristics of excluded studies).
Finally, we included five publications describing three distinct tri-
als; one trial was described in three publications (Cahen 2007)
(see Characteristics of included studies).
A cross-reference search of included trials and three additional re-
views (Deviere 2008;Gourgiotis 2007; van derGaag2007) yielded
no new eligible publications. Figure 1 is a flow-chart depicting the
flow of the selection process.
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Figure 1. Study flow diagram.
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Included studies
Two trials compared endoscopic intervention to surgical interven-
tion (Cahen 2007; Dite 2003). One compared surgical interven-
tion to conservative treatment (Nealon 1993). We did not iden-
tify any trials comparing endoscopic intervention to conservative
treatment. We did encounter one ongoing trial comparing endo-
scopic intervention to shamendoscopy (Characteristics of ongoing
studies). The characteristics of the included trials are described in
the table ’Characteristics of included studies’. A brief summary of
the most important characteristics is found below.
Studies comparing endoscopic versus surgical intervention
The two trials (Cahen 2007; Dite 2003) included a total of 111
patients, of whom 55 were in the endoscopic group and 56 in the
surgical group.
Cahen 2007 randomised 39 patients with advanced CP (all pa-
tients needed opioid analgesics before study inclusion), a dilated
pancreatic duct (> 5 mm) and without pancreatic head enlarge-
ment between endoscopy (19 patients) and surgery (20 patients).
The endoscopic intervention consisted of drainage of the pancre-
atic duct by ERCP with dilatation of strictures and stent place-
ment in the pancreatic duct, as necessary. In the case of persistent
strictures of the pancreatic duct, repeated dilation and stenting
were performed until patency of the duct was achieved. Patients
with large stones in the pancreatic duct (> 7 mm) underwent ex-
tracorporeal shock-wave lithotripsy (ESWL) before drainage. The
surgical group underwent surgical drainage of the pancreatic duct
by a longitudinal pancreaticojejunostomy as the intended treat-
ment. In one patient, aWhipple procedure was performed because
of peripancreatic inflammation. In another patient, stone extrac-
tion required a Frey procedure. The primary outcome was pain as
assessed by the Izbicki pain score (Izbicki 1998). Secondary out-
comes were proportion of patients with pain relief, quality of life
(SF-36), complications, mortality, duration of hospital stay, num-
ber of hospital readmittances, number of performed procedures,
change in pancreatic function, rate of conversion from endoscopic
treatment to surgery and technical success of the intervention. Fol-
low-up was two years. The study was prematurely terminated by
the safety committee on the bases of the significant difference in
outcome favouring the surgical group, with a P value of less than
0.001 regarding the primary outcome (pain on the Izbicki pain
score).
Dite 2003 included 140 patients in the study but only randomised
72 patients. The other 68 patients refused to be randomised in
the trial due to an outspoken preference for one of the treatment
modalities. Dite 2003 reported some outcomes for the randomised
group separately. However, baseline characteristics and other out-
comes (for example complications) were only reported for the
complete cohort.
In the randomised group 36 patients were allocated to each of
the two groups. All patients had advanced CP (at least three years
of failed medical management) and obstruction of the pancreatic
duct. Patients with enlargement of the pancreatic head were also
included. Endoscopic treatment consisted of drainage of the pan-
creatic duct by ERCP with dilatation of strictures and stent place-
ment in the pancreatic duct, as necessary. In the case of persistent
strictures of the pancreatic duct, repeated dilation and stenting
were performed until patency of the duct was achieved. ESWLwas
not performed as part of the endoscopic treatment. The surgical
group underwent any type of drainage or resection procedure con-
sidered appropriate by the surgeon. Data on the specific operation
were only reported for the complete cohort (80% resection proce-
dures and 20% drainage procedures). Primary outcomes were pain
relief and necessity for further intervention. Secondary outcomes
were change in body weight, presence of diabetes, complications
and mortality. Follow-up was five years.
Studies comparing surgical intervention versus conservative
treatment
Nealon1993was primarily a report of a cohort of 143patientswith
CP followed prospectively for 47.3 months. Within this cohort a
small pilot trial was conducted comparing surgical treatment to
conservative treatment. In this review we only included data from
the randomised trial.
In the published version of the trial, 17 patients with mild to
moderate CP (graded using a self developed grading system, see
Characteristics of included studies) and a dilated pancreatic duct
were randomised. Nine and eight patients were allocated to the
surgical and the conservative group, respectively. The only out-
come reported was the change in CP grade during follow-up. We
contacted the author for additional data and he provided us with
an update of the trial including data concerning an additional 15
patients that had been included since the publication.
The trial, therefore, included 32 patients with mild to moderate
(early stage) CP and dilated pancreatic duct, allocated to either
early surgical treatment (17 patients) or conservative treatment (15
patients). The surgical group was treated with surgical drainage
of the pancreatic duct by a longitudinal pancreaticojejunostomy.
The conservative group was kept on non-invasive treatment (spe-
cific treatment modalities unspecified). Pain and endocrine and
exocrine pancreatic function were reported as outcomes. The me-
dian follow-up period was 124 months.
Excluded studies
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All excluded publications that were not obviously excluded based
on title and abstract alone (that is full-text reviewing was necessary
for exclusion) are listed with the reason for exclusion in the table
’Characteristics of excluded studies’. Reasons for exclusion of these
studies were: non-randomised trial (five publications), comment
(two publications), study not about CP (one publication) and a
book chapter (one publication).
Risk of bias in included studies
Risk of bias varied considerably between the three included trials.
An overview of the different aspects of the risk of bias are illustrated
in the risk of bias summary figures (Figure 2; Figure 3). A detailed
description of the risk of bias assessment can be found in the
’Characteristics of included studies’ table.
Figure 2. Risk of bias graph: review authors’ judgements about each risk of bias item presented as
percentages across all included studies.
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Figure 3. Methodological quality summary: review authors’ judgements about each methodological quality
item for the three included trials.
Cahen 2007 was a well performed study with low risk of bias. Dite
2001 hadmanymethodological short-comings, including pseudo-
randomisation (allocation by alternation), unconcealed allocation,
lack of baseline characteristics and lack of an intention-to-treat
analysis (only a per protocol analysis was performed). For Nealon
1993 themethodological quality was not well reported. Therefore,
important aspects remained unclear.
Effects of interventions
See: Summary of findings for the main comparison Endoscopy
compared to surgery for painful obstructive chronic pancreatitis;
Summary of findings 2 Surgery compared to conservative
treatment for painful obstructive chronic pancreatitis
Endoscopic versus surgical intervention
Two studies comparing endoscopic versus surgical treatment were
identified (Cahen 2007; Dite 2003). The two studies mostly re-
ported different outcomes. Pooling of data was only possible in
regard to two outcomes: pain relief and new onset endocrine pan-
creatic insufficiency. A narrative review is provided for other out-
comes. Results of all outcomes considered to be of critical im-
portance according to the GRADE guideline (scored 7 or higher
on a 9-point score) were summarised in the Summary of findings
for the main comparison. These outcomes were pain relief, major
complications and mortality, quality of life, and endocrine and
exocrine pancreatic insufficiency.
Pain relief
13Endoscopic or surgical intervention for painful obstructive chronic pancreatitis (Review)
Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Both studies reported a higher proportion of patients with pain
relief (partial or complete) in the surgical group compared to the
endoscopic group (RR 1.62, 95% confidence interval (CI) 1.22
to 2.15) (Analysis 1.1; Figure 4). The proportion of patients with
complete pain relief was higher in the surgical group (RR 2.45,
95%CI 1.18 to 5.09) but there was no difference in the proportion
of patients with partial pain relief (Analysis 1.2; Figure 5).
Figure 4. Forest plot of comparison: 1 Endoscopy versus surgery, outcome: 1.1 Pain relief.
Figure 5. Forest plot of comparison: 1 Endoscopy versus surgery, outcome: 1.2 Complete and partial pain
relief.
Major post-interventional complications
Both studies reported on major complications associated with
study interventions (Table 1). There was no evidence for a differ-
ence between the surgical and endoscopic interventions.
Mortality
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Both studies reported on mortality. One death was reported in the
endoscopic group (Table 1). There was, therefore, no evidence for
a difference between the two groups.
Quality of life
Cahen 2007 reported the quality of life in both groups using the
SF-36 quality of life instrument (Brazier 1992) (Table 1). The
study showed that patients undergoing surgery scored higher (bet-
ter) on the physical health component of the SF-36 quality of life
scale. No difference was observed in themental health component
of the same instrument.
Minor post-interventional complications
Both studies reported on minor complications associated with
the study interventions (Table 1). There was no evidence for a
difference between the surgical and endoscopic interventions in
terms of these complications.
Pancreatic function
Endocrine pancreatic function was reported by both studies. The
proportion of new onset endocrine pancreatic insufficiency was
pooled (Analysis 1.3; Figure 6). There was no evidence for a dif-
ference between the two groups.
Figure 6. Forest plot of comparison: 1 Endoscopy versus surgery, outcome: 1.3 Endocrine pancreatic
insufficiency (new onset).
Exocrine pancreatic function was reported by Cahen 2007. In
the endoscopic group, exocrine pancreatic insufficiency developed
in six out of six patients (100%) with intact exocrine pancreatic
function at baseline, compared to one out of four patients (25%)
in the surgical group. The difference was statistically significant
(Table 1).
Number of needed endoscopic and surgical procedures
Both studies reported on this outcome but the data were not suit-
able for pooling. Cahen 2007 showed that patients in the surgi-
cal group underwent significantly fewer procedures than patients
in the endoscopic group (Table 1). Dite 2003 only reported this
outcome for the complete cohort (both randomised and non-ran-
domised patients). Patients in the surgical group required fewer
procedures compared to the endoscopic group (mean of six proce-
dures in the endoscopic group versus one procedure in the surgical
group).
Change in nutritional status
Dite 2003 reported a higher proportion of patients with increases
in body weight at the end of the follow-up period in the surgical
group compared to the endoscopic group (10 out of 36 (28%) for
the endoscopic group versus 17 out of 36 (47%) for the surgical
group) (Table 1). Although the study claimed that this difference
was statistically significant, we could not reproduce the reported
P value.
Duration of hospital stay
Cahen 2007 reported on this outcome (Table 1). There was no
evidence for a difference between the two groups.
Surgical intervention versus conservative treatment
We identified one trial (Nealon 1993) comparing surgical inter-
vention to conservative treatment for CP.We summarised the find-
ings of this study in Table 2. In summary, this study showed a
highly significant difference in favour of early surgical interven-
tion compared to conservative treatment in regard to pain relief
and pancreatic function. Partial or complete pain relief was ob-
served in 16 out of 17 (94%) patients in the surgical group versus
2 out of 15 (13%) in the conservative group. The proportion of
patients developing new onset endocrine and exocrine pancreatic
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insufficiency was, respectively, 2 out of 13 (15%) and 1 out of 15
(7%) patients in the surgical group versus 10 out of 12 (83%) and
11 out of 14 (79%) patients in the conservative group.
Results of all outcomes considered to be of critical importance ac-
cording to the GRADE guideline (that is pain relief, major com-
plications and mortality, quality of life and endocrine and ex-
ocrine pancreatic insufficiency) were summarised in the Summary
of findings 2.
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D I S C U S S I O N
Summary of main results
Endoscopic versus surgical intervention
The main finding of this review is that surgery achieves pain relief
in a higher proportion of patients compared to endoscopic treat-
ment, for patients with obstructive CP. This finding was consis-
tent in the two RCTs included (Cahen 2007; Dite 2003). The
observed difference had an evident clinical importance and was
long lasting. Additional benefits of surgery compared to endoscopy
were reported as well, mainly improved quality of life and a lower
risk of developing exocrine pancreatic insufficiency. The available
evidence could not identify differences between endoscopy and
surgery in terms of morbidity or mortality, mainly due to the small
size of the trials.
Surgical intervention to conservative treatment
This review identified one trial (Nealon 1993) comparing surgical
intervention to conservative treatment. This trial observed impor-
tant differences in terms of pain relief and preservation of pancre-
atic function in favour of the surgical group. Several methodolog-
ical and clinical factors, however, impede drawing reliable conclu-
sions from this trial (see the next sections: Overall completeness
and applicability of evidence and Quality of the evidence). The
main finding of this review regarding this topic is, therefore, that
in an early stage of CP surgery rather than conservative treatment
seems to be associated with potential benefits, which merits fur-
ther investigation.
Overall completeness and applicability of
evidence
Endoscopic versus surgical intervention
Cahen 2007 offered a complete comparison of both treatment
modalities with reporting of most outcomes that were of interest
to this review. The study of Dite 2003, on the other hand, reported
only a limited set of outcomes.
Regarding the applicability of the results, it should be noted that
both trials included only patients with severe (late) stage CP (opi-
oid dependency in Cahen 2007 and a period of > five years from
diagnosis and three years of failed medical management in Dite
2003). Therefore, results of these trials can only be generalized in
patients with similar severity.
Two concerns could be raised regarding the applicability of the
results of Dite 2003. First, the study did not exclude patients
with an inflammatory mass in the pancreas. The problem is that
endoscopy cannot fairly compete with surgery if such masses are
present since surgical resection (with or without pancreatic duct
drainage) is the treatment of choice in this case (van der Gaag
2007); especially since it was observed that 80% of the patients
in the surgical arm had some type of surgical resection procedure.
Secondly, the endoscopic intervention did not include the use of
ESWL. This modality is considered by experts to be an important
component of optimal endoscopic management (Dumonceau
2007).
The impact of these concerns on the applicability of the study is
difficult to assess. It seems acceptable that this could have led to
an unbalanced comparison, possibly leading to unjustly favouring
surgery over endoscopy. Regarding the first concern, however, the
authors did explicitly specify that patients were only included if a
consensus between the surgeon and the gastroenterologist was es-
tablished that both endoscopy and surgery were feasible therapeu-
tic alternatives. Therefore, the population of this trial may more
accurately resemble the population expected in the real clinical
situation. The authors would thereby have avoided a too narrow
patient selection that could compromise external validity (Yusuf
1990). Regarding the lack of ESWL in the endoscopic group, it
could be argued that in many centers ESWL is simply not (yet)
used as a routine treatment modality for this group of patients.
Dite 2003 may, therefore, more accurately resemble the current
situation in many hospitals.
Surgical intervention versus conservative treatment
Nealon 1993 only reported on two outcomes (pain relief and pan-
creatic function), and the authors especially did not report on po-
tential harms associated with either treatment. This trial thereby
only answered one part of the objective of the review. An impor-
tant point regarding the applicability of the results is that the con-
servative treatment was not explicitly specified in the report. Also,
the exclusion criteria are not clearly listed in the report. This limits
the ability to draw conclusions regarding the generalizability of
the results.
Quality of the evidence
Endoscopic versus surgical intervention
This review included two RCTs with a total of 111 patients.
Cahen 2007, despite its small sample size, is a high quality trial
with low risk of bias. The results, especially regarding the benefits
of surgery in terms of pain relief and quality of life, are convinc-
ing both statistically and clinically. The only remark that could be
made about the trial is that it was terminated at an unplanned in-
terim analysis. at 80% of the planned inclusion, due to significant
results of benefit. Termination of trials before full inclusion due
to benefit carries the risk of overestimating the treatment effect
(Montori 2005; Pocock 1999). However, both the observed effect
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as well as the P value have been corrected for this early termina-
tion. Moreover, the observed P value (P < 0.001) and the appli-
cation of an independent safety commission to take the decision
of trial termination give more confidence in the correctness of the
decision.
Dite 2003 had several methodological flaws. First, allocation was
performed by alternation rather than true randomisation. This
method has two problems, the generated allocation is not random
and it makes allocation concealment impossible (Randelli 2008).
Absence of allocation concealment has been shown to significantly
overestimate the treatment effects in RCTs, to up to 40% (Schulz
1995). In its defence,Dite 2003 did specify that patients were only
included if a consensus was established by a consulting gastroen-
terologist and surgeon regarding the inclusion of patients. While
this is by no means a substitution of proper randomisation and
allocation concealment, reaching consensus by physicians of two
different specialities with competing interests may have reduced
the selection bias associated with unconcealed allocation. Further
limitations of the study were the exclusion of patients who were
non-compliant to follow-up (per protocol analysis rather than an
intention-to-treat analysis) and the lack of baseline characteristics.
In general, the overall quality andquantity of the available evidence
is, in our opinion, sufficient to draw conclusions about benefits
of both interventions, especially regarding pain relief. The fact
that the two RCTs show consistent results and that the observed
differences aremore evident (both statistically and clinically) in the
study with low risk of bias, increase the reliability of the observed
differences. On the other hand, the small size of the trials makes
drawing conclusions regarding outcomes with potentially a small
difference between the interventions (for example complications
and mortality) beyond reach. Also, the lack of evidence of benefit
regarding other more objective outcomes (for example pancreatic
function) is a drawback in the quality of the evidence.
Surgical intervention versus conservative treatment
As stated earlier, one trial Nealon 1993 including 32 patients was
identified for this comparison. This trial has limitations as the trial
had a small sample size and lacked a formal sample size calculation,
the conservative arm was not clearly defined, the inclusion of pa-
tients was conducted over a long period of time and the method-
ology was not clearly reported. This could be partly explained by
the study being a pilot RCT intended to generate a hypothesis
to be tested in a larger randomised trial (Nealon 1993). Another
potential explanation is that the study was set up about 18 years
ago, in a period when knowledge of the methodology of RCTs was
not commonly available.
Taking the above mentioned in mind, this trial is best considered
as a hypothesis-generating pilot trial that should lead to further
studying of the promising results shown by this trial before con-
clusions can be drawn for current practice.
Potential biases in the review process
Obtaining all relevant data was the most challenging aspect of
this review. For all studies included, some potentially relevant
data were missing in the original reports. We were able to obtain
some of these data by contacting the authors of the trials, but de-
spite repeated contacting of authors some data remained missing.
Nonetheless, it is not likely that these data would have changed
the conclusions of the review, especially since most concerned sec-
ondary outcomes.
Finally, this review once again shows that reporting of several as-
pects in trials, including essential aspects like baseline character-
istics, is still inadequate in many cases. This clearly illustrates the
need to adhere to guidelines for reporting research to make the va-
lidity of studies more assessable. Caution should be applied, how-
ever, in critically appraising poorly reported trials since evidence
showed that this is not always interchangeable with bad method-
ology (Soares 2004).
Agreements and disagreements with other
studies or reviews
Endoscopic versus surgical intervention
A review by Deviere 2008 comparing endoscopic to surgical treat-
ment for CP and including the same two RCTs as in our review
concluded that the low number of patients in the trials and the
differences in methodology did not allow for drawing any conclu-
sions about the choice between endoscopy and surgery. Deviere
2008 stated that “because of paucity in the available RCTs, physi-
cians and surgeons must rely on their own experience”.
We do not entirely agree with these conclusions. Choosing indi-
vidual experiences and preferences (level V evidence) as a basis
for decision making, despite the availability of two RCTs (level 1
evidence) showing consistent results in favour of one treatment, is
in our opinion too conservative. This is especially so since one of
these studies is a well conducted study with low risk of bias and
the endoscopic treatment in this trial was performed in centres
with high expertise and performing of ESWL for large pancreatic
duct stones (Cahen 2007). We think that serious efforts should
be made to interpret the available evidence in a way that is most
beneficial to patients, taking into account the limitations regard-
ing the generalizability and validity of this evidence.
Surgical intervention versus conservative treatment
Although Nealon 1993 is the only RCT that has compared surgi-
cal intervention at an early stage of CP to conservative interven-
tion, the results are in agreement with other non-randomised stud-
ies. Clinically, two non-randomised cohort studies have shown
that surgical interventions, especially drainage procedures, have
the potential to delay the progressive loss of pancreatic function in
20Endoscopic or surgical intervention for painful obstructive chronic pancreatitis (Review)
Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
CP patients (Maartense 2004; Nealon 1993). This is in line with
findings from experimental studies. In an experimental model of
early versus late surgical drainage for CP in piglets, it was observed
that the histology of the pancreas and exocrine pancreatic function
were significantly better in the early surgical group compared to
the late surgical group (Lamme 2007).
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Endoscopic versus surgical intervention
For patients with severe CP (that is with pain intractable to opioid
medication) and a dilated pancreatic duct this review shows that
surgery is superior to endoscopy in term of benefits (that is pain
control and quality of life). However, when it comes to morbidity
and mortality, this review is not able to draw reliable conclusions.
Therefore, we believe that surgery should be considered the treat-
ment of choice for patients with severe CP, but decisions for either
intervention should be made after informing patients about risks
associated with both treatments and openly discussing the gaps in
current knowledge.
Surgical intervention versus conservative treatment
Regarding this comparison, this review can not draw reliable con-
clusions for clinical practice. Surgery rather than conservative
treatment at an early stage of CP seems a promising approach, but
more evidence is needed.
Implications for research
Endoscopic versus surgical intervention
This review identified two aspects regarding the comparison of
endoscopic versus surgical intervention for CP which need further
investigation. First, endoscopic and surgical interventions should
be compared in regard to morbidity and mortality, preferably in a
large well conducted trial. Secondly, the effectiveness and compli-
cations of endoscopic versus surgical intervention for patients with
early stage CP (rather than late stage CP) should be investigated.
Combining these two aspects by conducting a large RCT in pa-
tients with early stage CP could be an efficient way to answer both
questions simultaneously. Future trials should focus on objective
outcomes as well as those that are reported by patients to provide
a more complete picture of benefits and harms.
Surgical intervention versus conservative treatment
This review identified one pilot trial showing that surgery rather
than conservative treatment for early CP may bring important
benefits to patients in terms of pain relief and preservation of pan-
creatic function. Investigating these results in a large well con-
ducted RCT, with attention to benefit, harm and cost-effective-
ness of both interventions, is recommended.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Cahen 2007
Methods Study design: randomised controlled trial
Setting of study: single center, AMC Amsterdam, the Netherlands
Follow-up period: 24 months
Loss to follow-up: one patient in the surgical group
Type of analysis: intention-to-treat analysis
Sample size calculations: yes, a sample size of 50 patients was calculated
Participants Number of participants: 39 (19 in the endoscopy group, 20 in the surgical group)
Gender: endoscopy group: 11 males, 8 females; surgery group: 15 males, 5 females
Age [mean (SD)]: endoscopy group: 52 years (9); surgery group: 46 years (12)
BMI [mean (SD)]: endoscopy group: 21 kg (4. 1); surgery group: 21 kg (3. 7)
Type of pain:
• endoscopy group: 7 patients with intermittent pain (type A), 12 patients with
continuous pain (type B)
• surgery group: 9 patients with intermittent pain (type A), 11 patients with
continuous pain (type B)
Inclusion criteria:
• Established CP
• Obstruction of pancreatic duct (>5 mm)
• No pancreatic head enlargement
• Severe recurrent pancreatic pain intractable to non-narcotic analgesics
Exclusion criteria:
• Age <18 or > 80 years
• Enlargement of pancreatic head > 4 cm
• Contra-indications to surgery or endoscopic interventions
• Previous pancreatic surgery
• Suspected pancreatic malignancy, or life expectancy < 2 years
• Pregnancy
Duration of symptoms: endoscopy group: 16 months (SD 14); surgery group 21months
(SD 19)
Ongoing alcohol abuse at randomisation: endoscopy group: 0 patients; surgical group:
5 patients
Ongoing smoking at randomisation: endoscopy group: 15 patients; surgical group: 17
patients
Interventions Endoscopic drainage versus surgical drainage:
• Endoscopic drainage: endoscopic drainage of the pancreatic duct by ERCP with
(repeated) dilatation and stent placement if required. Patients with large stones in the
pancreatic duct (>7mm) underwent extracorporeal shock-wave lithotripsy (ESWL)
before drainage.
• Surgical drainage: surgical drainage of the pancreatic duct by means of a
longitudinal pancreaticojejunostomy as intended treatment. In one patient, a Whipple
procedure was performed because of peripancreatic inflammation. In another patient,
stone extraction required a Frey procedure.
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Cahen 2007 (Continued)
Endoscopic experience: study interventions were performed by experienced endoscopists
(performed > 1000 ERCPs)
Surgical experience: surgical procedures were performed by experienced pancreatic sur-
geons (no specific criteria stated)
Outcomes Primary outcome (prespecified in method section):
• Pain score (Izbicki questionnaire)
Secondary outcomes (prespecified in method section):
• Pain relief (defined by Izbicki score)
• Physical and mental health (SF-36 questionnaires)
• Post-interventional complications
• Length of hospital stay
• Number of performed procedures
• Change in pancreatic function
• Mortality
Other outcomes (results reported, but not specified in method section):
• Conversion to surgery
• Technical success of intervention
• Hospital re-admittance
Time points of outcomes: 6 weeks and 3, 6, 12, 18 and 24 months
Notes • Study was terminated prematurely by the safety committee on the bases of
significant difference in outcome favouring the surgical group with a P value of less
than 0.001 regarding the primarily outcome (pain on the Izbicki pain score).
• Author provided us with additional methodological information and data.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Automated assignment system.
Allocation concealment (selection bias) Low risk Specifically stated.
Blinding (performance bias and detection
bias)
All outcomes
High risk
Incomplete outcome data (attrition bias)
All outcomes
Low risk Proportion of loss to follow-up did not ex-
ceed 20%.
Selective reporting (reporting bias) Low risk All relevant and pre-specified outcomes re-
ported.
Other bias Low risk Study terminated prematurely, but authors
performed adequate adjustment for treat-
ment effect and P value for early termina-
tion
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Dite 2003
Methods Study design: pseudo-randomised controlled trial (alternating allocation)
Setting of study: single center, University Hospital Brno, Czech Republic
Follow-up period: 5 years
Loss to follow up: patients not compliant to follow-up were excluded
Type of analysis: per protocol analysis
Sample size calculation: yes, a sample size of 140 patients was calculated
Participants Number of randomised participants: 72 (36 in the endoscopy group, 36 in the surgical
group). The population of the RCT is part of a larger prospective cohort reported in the
same publication. The total sample of the cohort is 140
Gender: not specified for the randomised group (only for the complete cohort, with 119
males and 21 females)
Age: not specified for the randomised group (only for the complete cohort with a mean
age of 41.7 years ranging between 26-53)
BMI: not specified
Type of pain (continuous vs recurrent flair ups): not specified
Inclusion criteria:
• Established CP
• Obstruction of pancreatic duct (dilated pancreatic duct)
• Painful CP (pain score > 3 on the Melzack’s pain score)
• Failure of conservative management in the previous 3 years
• Duration clinical CP for more than 5 years
• Consensus of surgeon and gastroenterologist regarding suitability of patient for
both endoscopy and surgery
Exclusion criteria:
• Age <18 or > 70 years
• Previous interventional therapy for CP (surgery, endoscopy or nerve block)
• Suspected pancreatic malignancy
• Non-compliance to follow-up examinations
• Pregnancy
Duration of symptoms: > 5 years (inclusion criteria)
Ongoing alcohol abuse and/or smoking at randomisation: not reported
Interventions Endoscopic drainage versus surgical intervention (drainage and resection):
• Endoscopic drainage: endoscopic drainage of the pancreatic duct by ERCP with
pancreatic sphincterotomy, stone extraction, dilation of strictures and stenting, as
appropriate. ESWL was not applied as part of the endoscopic intervention.
• Surgical intervention: choice of operation was dependent on the morphology of
the pancreas on pre-operative imaging. Pancreaticojejunostomy was performed in
patients with absence of focal pancreatic enlargement. In patients in whom disease was
limited predominantly to the pancreatic head, either duodenum-preserving pancreatic
head resection or pancreatoduodenectomy (Whipple resection) were performed. CP
predominantly affecting the pancreatic tail was treated by left pancreatic resection.
Endoscopic experience: study interventions were performed by two experienced endo-
scopists (performed > 200 drainage procedures)
Surgical experience: surgical procedures was performed by one abdominal surgeon (per-
formed 90 pancreatic operations before the start of the study)
27Endoscopic or surgical intervention for painful obstructive chronic pancreatitis (Review)
Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Dite 2003 (Continued)
Outcomes Primary outcome (prespecified in method section):
• Pain relief (defined by Melzack score)
• Necessity for further interventions
Secondary outcomes (prespecified in method section):
• Change in body weight
• Presence of diabetes
Other outcomes (results reported, but not specified in method section):
• Complcations
• Mortality
Time points of outcomes: 6 months and 1, 3 and 5 years
Notes • The population of the RCT is part of a larger prospective cohort reported in the
same publication.
• Author provided us with additional information regarding methodology of the
study, but not with additional data regarding missing baseline characteristics and
outcomes.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
High risk Allocation by alternation.
Allocation concealment (selection bias) High risk
Blinding (performance bias and detection
bias)
All outcomes
High risk
Incomplete outcome data (attrition bias)
All outcomes
High risk Patients not compliant to follow-up were
excluded.
Selective reporting (reporting bias) Low risk All pre-specified outcomes reported.
Other bias Unclear risk • The study did not present a baseline
table with relevant patient characteristics
and potential confounders (e.g. smoking,
alcohol use, pre-operative pain, etc).
• Study allowed for inclusion of
patients with enlarged pancreatic head.
These patients potentially benefit more
from surgery than endoscopy, since
surgery allows for resection of the
inflamed mass while endoscopy does not.
28Endoscopic or surgical intervention for painful obstructive chronic pancreatitis (Review)
Copyright © 2012 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Nealon 1993
Methods Study design: randomised controlled trial
Setting of study: single center, The University of Texes Medical Branch, Galveston, Texas
Follow-up period: median 124 months
Loss to follow-up: no
Type of analysis: intention-to-treat analysis
Sample size calculations: no (pilot study)
Participants Number of participants: 32 patients (17 in the surgical group, 15 in the conservative
group)
Gender: not specified
Age [mean]: 41.7 years in the surgical group, 44.6 in the conservative group
Inclusion criteria:
• Established CP
• Dilation of pancreatic duct
• Mild, non-debilitating pain
• Mild to moderate grade of CP: using a self developed grading system (1 point for
morphology on ERCP, 2 points for exocrine function, 2 points for endocrine function)
. Patients were categorized as mild/moderate (3 or less points) or severe CP (more then
3 points).
Exclusion criteria: not specified
Duration of symptoms: not specified
Ongoing alcohol abuse at randomisation: not specified for patients within the RCT
Ongoing smoking at randomisation: not specified
Interventions Surgical drainage versus conservative treatment
• Surgical drainage: surgical drainage of the pancreatic duct by means of a
longitudinal pancreaticojejunostomy. With choledochoenterostomy and pseudocyst
drainage when deemed necessary. In patients with duodenum obstruction a
gastrojejunostomy was performed as well.
• Conservative treatment: not specified.
Surgical experience: not specified
Outcomes Primary and secondary outcomes (prespecified in method section): not specified as such
Outcomes (specified in method section):
• Presence of abdominal pain
• Grade of CP (using the self developed grading system described above)
Other outcomes (results reported, but not specified in method section):
• Exocrine and endocrine pancreatic function
Time points of outcomes: standardised follow-up each 14 to 16 months
Notes • The population of the RCT is part of a larger prospective cohort reported in the
same publication.
• The author only published the results of the first 17 patients. Other data were
provided to us by the author for the purpose of this review.
Risk of bias
Bias Authors’ judgement Support for judgement
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Nealon 1993 (Continued)
Random sequence generation (selection
bias)
Unclear risk Last digit of the MRI number was used
(odd versus even digits). It is unclear if the
numbers generated by such a mechanism
are truly random
Allocation concealment (selection bias) High risk
Blinding (performance bias and detection
bias)
All outcomes
High risk
Incomplete outcome data (attrition bias)
All outcomes
Low risk Proportion of losses to follow-up did not
exceed 20%.
Selective reporting (reporting bias) Low risk All specified data were reported.
Other bias Unclear risk The study did not present a baseline ta-
ble with relevant patient characteristics and
potential confounders
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Alexakis 2005 Abstract was not electronically available. Publication appeared to be a book chapter. Not an original publication
Cahen 2011 Report is only available in abstract form. This is a long-term report of one of the included trials. Final report
will be added to the review when published
Chang 2010 Diagnostic study comparing endoscopic ultrasound with transabdominal ultrasound for upper abdominal pain
Connors 1993 Abstract was not electronically available. Publication is a comment on another study regarding use of stents in
acute recurrent pancreatitis. Chronic pancreatitis patients were excluded
Dumonceau 2007 Randomised trial comparing endoscopic intervention to an alternative treatment, i.e. extracorporeal shock-wave
lithotripsy (ESWL)
Iqbal 2009 Non-randomised trial comparing endoscopic intervention to surgical intervention in pediatric patients
Knoefel 1997 Abstract was not electronically available. Publication only provides comment on the Nealon 1993 study. No
original data.
Laramee 2010 Publication (only in abstract form) is a report of an economic evaluation based on a review of literature
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(Continued)
Lee 2005 Abstract was not electronically available. Publication (only in abstract form) is a report of a non-randomised
series
Levy 1989 Abstract was not electronically available. Publication (only in abstract form) is a report of a non-randomised
comparison
Lipsky 1993 Abstract was not electronically available. Study compares two techniques for treatment of oesophageal strictures
Noda 2004 Abstract was not electronically available. Publication (only in abstract form) is a report of a non-randomised
comparison of different methods of litholysis
Sauer 2008 Abstract was not electronically available. Publication (only in abstract form) is a report of a non-randomised
comparison
Seiler 2009 No abstract. Publication is a commentary on a protocol of a randomised trial comparing endoscopic intervention
to sham intervention (Wilcox 2009)
Wagh 2008 Abstract was not electronically available. Publication (only in abstract form) describes a cohort of patients,
without comparison
Characteristics of ongoing studies [ordered by study ID]
Wilcox 2009
Trial name or title A randomised trial comparing endoscopic stenting to a sham procedure for chronic pancreatitis
Methods Randomised controlled trial
Participants Patients with typical abdominal pain, imaging confirmation of CP and endoscopic retrograde cholangiopan-
creatography (ERCP) confirmation of PD stricture
Interventions ERCP with sphincterotomy and PD stenting versus sham procedure
Outcomes Primary endpoint: reduction in abdominal pain.
Secondary endpoints: reduction in narcotic use as documented by pill counts; improvement in quality of
life as assessed by the quality of life instruments; reduction in healthcare utilization (emergency room, clinic
visits, or hospitalizations); weight gain; return to employment and reduction in number of missed days from
work
Starting date Not stated
Contact information Dr C Mel Wilcox, University of Alabama at Birmingham, Division of Gastroenterology & Hepatology, 703
19th Street South, ZRB Room 633, Birmingham, AL 35294-0007, USA. Tel: (205) 975-4958, Fax: (205)
934-1546. E-mail: melw@uab.edu
Notes
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D A T A A N D A N A L Y S E S
Comparison 1. Endoscopy versus surgery
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Pain relief 2 111 Risk Ratio (M-H, Fixed, 95% CI) 1.62 [1.22, 2.15]
2 Complete and partial pain relief 2 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
2.1 Complete pain relief 2 111 Risk Ratio (M-H, Fixed, 95% CI) 2.45 [1.18, 5.09]
2.2 Partial pain relief 2 111 Risk Ratio (M-H, Fixed, 95% CI) 1.29 [0.83, 1.99]
3 Endocrine pancreatic
insufficiency (new onset)
2 102 Risk Ratio (M-H, Fixed, 95% CI) 0.98 [0.55, 1.76]
Analysis 1.1. Comparison 1 Endoscopy versus surgery, Outcome 1 Pain relief.
Review: Endoscopic or surgical intervention for painful obstructive chronic pancreatitis
Comparison: 1 Endoscopy versus surgery
Outcome: 1 Pain relief
Study or subgroup Surgery Endoscopy Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Cahen 2007 15/20 6/19 21.9 % 2.38 [ 1.17, 4.82 ]
Dite 2003 31/36 22/36 78.1 % 1.41 [ 1.05, 1.89 ]
Total (95% CI) 56 55 100.0 % 1.62 [ 1.22, 2.15 ]
Total events: 46 (Surgery), 28 (Endoscopy)
Heterogeneity: Chi?? = 2.00, df = 1 (P = 0.16); I?? =50%
Test for overall effect: Z = 3.34 (P = 0.00085)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours endoscopy Favours surgery
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Analysis 1.2. Comparison 1 Endoscopy versus surgery, Outcome 2 Complete and partial pain relief.
Review: Endoscopic or surgical intervention for painful obstructive chronic pancreatitis
Comparison: 1 Endoscopy versus surgery
Outcome: 2 Complete and partial pain relief
Study or subgroup Surgery Endoscopy Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Complete pain relief
Cahen 2007 8/20 3/19 38.1 % 2.53 [ 0.79, 8.15 ]
Dite 2003 12/36 5/36 61.9 % 2.40 [ 0.94, 6.12 ]
Subtotal (95% CI) 56 55 100.0 % 2.45 [ 1.18, 5.09 ]
Total events: 20 (Surgery), 8 (Endoscopy)
Heterogeneity: Chi?? = 0.01, df = 1 (P = 0.94); I?? =0.0%
Test for overall effect: Z = 2.41 (P = 0.016)
2 Partial pain relief
Cahen 2007 7/20 3/19 15.3 % 2.22 [ 0.67, 7.34 ]
Dite 2003 19/36 17/36 84.7 % 1.12 [ 0.70, 1.78 ]
Subtotal (95% CI) 56 55 100.0 % 1.29 [ 0.83, 1.99 ]
Total events: 26 (Surgery), 20 (Endoscopy)
Heterogeneity: Chi?? = 1.15, df = 1 (P = 0.28); I?? =13%
Test for overall effect: Z = 1.13 (P = 0.26)
0.01 0.1 1 10 100
Favours endoscopy Favours surgery
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Analysis 1.3. Comparison 1 Endoscopy versus surgery, Outcome 3 Endocrine pancreatic insufficiency (new
onset).
Review: Endoscopic or surgical intervention for painful obstructive chronic pancreatitis
Comparison: 1 Endoscopy versus surgery
Outcome: 3 Endocrine pancreatic insufficiency (new onset)
Study or subgroup Surgery Endoscopy Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Cahen 2007 1/16 3/14 21.1 % 0.29 [ 0.03, 2.50 ]
Dite 2003 14/36 12/36 78.9 % 1.17 [ 0.63, 2.16 ]
Total (95% CI) 52 50 100.0 % 0.98 [ 0.55, 1.76 ]
Total events: 15 (Surgery), 15 (Endoscopy)
Heterogeneity: Chi?? = 1.53, df = 1 (P = 0.22); I?? =35%
Test for overall effect: Z = 0.06 (P = 0.95)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours endoscopy Favours surgery
A D D I T I O N A L T A B L E S
Table 1. Results of studies comparing endoscopic to surgical treatment
Cahen 2007 Dite 2003
Outcome Endoscopy
(N=19)
Surgery
(N=20)
P value Endoscopy
(N=36)
Surgery
(N=36)
P value
Major complica-
tions [N (%)]
0 (0%) 1 (5%) NS 5 (8%)* 3 (4%)* NS
Mortality [N
(%)]
1 (5%) 0 (0%) NS 0 (0%) 0 (0%) NS
Quality
of life score (SF-
36) [mean (SD)]
- Physical health
component
38 (9) 47 (7) 0.003 - - -
- Mental health
component
40 (9) 45 (9) NS - - -
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Table 1. Results of studies comparing endoscopic to surgical treatment (Continued)
Minor complica-
tions [N (%)]
11 (58%) 6 (30%) NS 0 (0%)* 3 (4%)*
Number of inter-
ventions [mean
(range)]
9 (1 to 21) 3 (1 to 9) < 0.001 6 (4 to 9)* 1 (1 to 3)* N/A
Change in nutri-
tional status [N
(%)]
- Increase from
baseline
- - - 10 (28%) 17 (47%) NS
- Unchanged
from baseline
- - - 9 (25%) 9 (25%) NS
- Decrese from
baseline
- - - 17 (47%) 10 (28%) NS
Duration of hos-
pital stay [me-
dian (range)]
8 (0 to 128) 11 (5 to 59) NS - -
Endoscopy
(N=6)**
Surgery
(N=4)**
P value Endoscopy
(N=36)
Surgery
(N=36)
P value
Exocrine pancre-
atic insufficiency
(new onset) [N
(%)]
6 (100%) 1 (25%) 0.03 - - -
* For this outcome Dite 2003 only reported the result for the complete cohort (140 patients, 64 in the endoscopic group and 76 in the
surgical group. Only part of the patients were randomised (72 randomised and 68 non-randomised patients).
** N consists of all patients without exocrine pancreatic insufficiency at baseline.
NS = not significant; N/A = not available.
Table 2. Results of Nealon 1993
Outcome Surgery
(N=17)
Conservative
(N=15)
P value
Pain relief (partial or complete)
[N (%)]
16 (94%) 2 (13%) < 0.001
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Table 2. Results of Nealon 1993 (Continued)
- Complete pain relief [N (%)] 14 (82%) 0 (0%) < 0.001
- Partial pain relief [N (%)] 2 (12%) 2 (13%) NS
Surgery
(N=13)*
Conservative
(N=12)*
P value
New onset endocrine pancre-
atic insufficiency [N (%)]
2 (15%) 10 (83%) 0.001
Surgery
(N=15)*
Conservative
(N=14)*
P value
New onset exocrine pancreatic
insufficiency [N (%)]
1 (7%) 11 (79%) < 0.001
* N represents the number of patients without exocrine pancreatic insufficiency at baseline.
NS=not significant.
A P P E N D I C E S
Appendix 1. CENTRAL search strategy
1. exp Pancreatitis, Chronic/
2. chronic pancreatitis.mp.
3. 1 or 2
4. ((autoimmun$ or auto-immun$ or Tropical or hereditar$ or familiar$) and pancreatitis).mp.
5. exp Pancreatitis, Alcoholic/
6. exp Pancreatic Ducts/
7. obstruction.mp.
8. 6 and 7
9. (Pancrea$ adj2 Duct$ adj2 obstruction$).mp.
10. 8 or 9
11. alcohol intoxicat$.mp.
12. (autoimmunity$ or auto-immunity$).mp.
13. Hypertriglyceridemia/
14. Hypercalcemia/
15. 12 or 11 or 14 or 13
16. Pancreas/
17. 15 and 16
18. 3 or 4 or 5 or 10 or 17
19. Cholangiopancreatography, Endoscopic Retrograde/ or Drainage/ or Endoscopy/ or Endoscopy, Digestive System/
20. ERCP.mp.
21. Decompression/
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22. Sphincterotomy, Endoscopic/
23. Dilatation/
24. Stents/
25. or/19-24
26. 16 and 25
27. Surgery/
28. Surgical Procedures, Operative/
29. 27 or 28
30. 29 and 16
31. Pancreaticojejunostomy/
32. beger.mp.
33. Frey.mp.
34. (puestow or Partington-Rochelle).mp.
35. Pancreatectomy/
36. ((left or tail or distal or caudal) and (resection or pancreatectomy)).mp.
37. Pancreaticoduodenectomy/ or whipple.mp.
38. (dilation adj2 pancrea$).mp.
39. or/31-38
40. 18 or 26 or 30 or 39
Appendix 2. MEDLINE search strategy
1. randomized controlled trial.pt.
2. controlled clinical trial.pt.
3. randomized.ab.
4. placebo.ab.
5. drug therapy.fs.
6. randomly.ab.
7. trial.ab.
8. groups.ab.
9. or/1-8
10. (animals not (humans and animals)).sh.
11. 9 not 10
12. exp Pancreatitis, Chronic/
13. chronic pancreatitis.mp.
14. 12 or 13
15. ((autoimmun$ or auto-immun$ or Tropical or hereditar$ or familiar$) and pancreatitis).mp.
16. exp Pancreatitis, Alcoholic/
17. exp Pancreatic Ducts/
18. obstruction.mp.
19. 17 and 18
20. (Pancrea$ adj2 Duct$ adj2 obstruction$).mp.
21. 19 or 20
22. alcohol intoxicat$.mp.
23. (autoimmunity$ or auto-immunity$).mp.
24. Hypertriglyceridemia/
25. Hypercalcemia/
26. 23 or 22 or 25 or 24
27. Pancreas/
28. 26 and 27
29. 14 or 15 or 16 or 21 or 28
30. Cholangiopancreatography, Endoscopic Retrograde/ or Drainage/ or Endoscopy/ or Endoscopy, Digestive System/
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31. ERCP.mp.
32. Decompression/
33. Sphincterotomy, Endoscopic/
34. Dilatation/
35. Stents/
36. or/30-35
37. Surgery/
38. Surgical Procedures, Operative/
39. 37 or 38
40. 39 and (14 or 27)
41. Pancreaticojejunostomy/
42. beger.mp.
43. Frey.mp.
44. (puestow or Partington-Rochelle).mp.
45. Pancreatectomy/
46. ((left or tail or distal or caudal) and (resection or pancreatectomy)).mp.
47. Pancreaticoduodenectomy/ or whipple.mp.
48. (dilation adj2 pancrea$).mp.
49. or/41-48
50. 36 or 40 or 49
51. 11 and 29 and 50
Appendix 3. EMBASE search strategy
1. (random$ or placebo$).ti,ab.
2. ((single$ or double$ or triple$ or treble$) and (blind$ or mask$)).ti,ab.
3. controlled clinical trial$.ti,ab.
4. RETRACTED ARTICLE/
5. or/1-4
6. (animal$ not human$).sh,hw.
7. 5 not 6
8. exp Pancreatitis, Chronic/
9. chronic pancreatitis.mp.
10. 8 or 9
11. ((autoimmun$ or auto-immun$ or Tropical or hereditar$ or familiar$) and pancreatitis).mp.
12. exp Pancreatitis, Alcoholic/
13. exp Pancreatic Ducts/
14. obstruction.mp.
15. 13 and 14
16. (Pancrea$ adj2 Duct$ adj2 obstruction$).mp.
17. 15 or 16
18. alcohol intoxicat$.mp.
19. (autoimmunit$ or auto-immunit$).mp.
20. Hypertriglyceridemia/
21. Hypercalcemia/
22. 19 or 18 or 21 or 20
23. Pancreas/
24. 22 and 23
25. 10 or 11 or 12 or 17 or 24
26. Cholangiopancreatography, Endoscopic Retrograde/ or Drainage/ or Endoscopy/ or Endoscopy, Digestive System/
27. ERCP.mp.
28. Decompression/
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29. Sphincterotomy, Endoscopic/
30. Dilatation/
31. Stents/
32. or/26-31
33. Surgery/
34. Surgical Procedures, Operative/
35. 33 or 34
36. 35 and (10 or 23)
37. Pancreaticojejunostomy/
38. beger.mp.
39. Frey.mp.
40. (puestow or Partington-Rochelle).mp.
41. Pancreatectomy/
42. ((left or tail or distal or caudal) and (resection or pancreatectomy)).mp.
43. Pancreaticoduodenectomy/ or Whipple.mp.
44. (dilation adj2 pancrea$).mp.
45. or/37-44
46. 32 or 36 or 45
47. 7 and 25 and 46
Appendix 4. Conference Proceeding Index - Science search strategy
#1 Topic=(chronic pancreatitis) OR Title=(chronic AND pancreatitis)
#2 Topic=((autoimmun* OR auto-immun* OR tropical OR hereditar* OR familiar*) AND (pancreatitis))
#3 Title=((autoimmun* OR auto-immun* OR tropical OR hereditar* OR familiar*) AND (pancreatitis))
#4 Topic=((pancrea*) AND (obstruction OR “alcohol intox*” OR autoimmune* OR auto-immun* OR Hypertriglyceridem* OR
Hypercalcem*))
#5 Title=((pancrea*) AND (obstruction OR “alcohol intox*” OR autoimmune* OR auto-immun* OR Hypertriglyceridem* OR
Hypercalcem*))
#6 #1 OR #2 OR #3 OR #4 OR #5
#7 Topic=((endosc* OR ERCP OR decompression OR drainage OR sphincterotomy OR dilatation OR stent* OR surg* OR beger
OR frey OR PJ OR pancreaticojejunostomy OR puestow OR partington-rochelle OR PD OR Pancreaticoduodenectomy OR PPPD
OR whipple))
#8 Title=((endosc* OR ERCP OR decompression OR drainage OR sphincterotomy OR dilatation OR stent* OR surg* OR beger OR
frey OR PJ OR pancreaticojejunostomy OR puestow OR partington-rochelle OR PD OR Pancreaticoduodenectomy OR PPPD OR
whipple))
#9 Topic=((left OR tail OR distal OR caudal) AND (resection OR pancreatectomy))
#10 Title=((left OR tail OR distal OR caudal) AND (resection OR pancreatectomy))
#11 #7 OR #8 OR #9 OR #10
#12 #6 AND #11
H I S T O R Y
Protocol first published: Issue 3, 2009
Review first published: Issue 1, 2012
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D E C L A R A T I O N S O F I N T E R E S T
None known
S O U R C E S O F S U P P O R T
Internal sources
• None, Not specified.
External sources
• None, Not specified.
D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
This review has been conducted in accordance with the published protocol.
I N D E X T E R M S
Medical Subject Headings (MeSH)
Constriction, Pathologic [complications]; Endoscopy, Gastrointestinal [adverse effects; ∗methods]; Pain [etiology; ∗surgery]; Pain
Management [∗methods]; Pancreatic Ducts; Pancreatitis, Chronic [∗surgery]; Pressure [adverse effects]; Randomized Controlled Trials
as Topic
MeSH check words
Humans
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